Orchid Chemicals & Pharmaceuticals Limited

Orchid Research Laboratories Limited

Maruthikumar Narayanam

Sriram K Rajagopal

Ravikumar Tadiparthi

Venkatesan Parameswaran

Virendra Kachhadia

Uma Ramachandran

Ganapavarapu Veera Raghava Sharma

Sukunath Narayanan

Venkatesan Janarthanam

Sathyanarayana Gadde

Durairaj Peter Bhakiaraj

Sathya Narayana Thara

Gaddam Om Reddy

Gopalan Balasubramanian

Shridhar Narayanan

Sanjeev Saxena

Akella Satya Surya Visweswara Srinivas

Sappanimuthu Thirunavukkarasu

Narayanan Surendran

Visweswara Akella Satya Surya Srinivas

Lolaknath Santosh Vishwakarma

Thirunavukkarasu Sappanimuthu

Kilambi Narsimhan

Kilambi Narasimhan

Om Reddy Gaddam

Described are novel heterocyclic compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof. These compounds are useful in the treatment of immunological diseases, inflammation, pain disorder, rheumatoid arthritis; osteoporosis; multiple myeloma; uveititis; acute and chronic myelogenous leukemia; atherosclerosis; cancer; cachexia; ischemic-induced cell damage; pancreatic beta cell destruction; osteoarthritis; rheumatoid spondylitis; gouty arthritis; inflammatory bowel disease; ARDS; psoriasis; Crohn's disease; allergic rhinitis; ulcerative colitis; anaphylaxis; contact dermatitis; muscle degeneration; asthma; COPD; bone resorption diseases; multiple sclerosis; sepsis; septic shock; toxic shock syndrome and fever. More particularly these compounds are useful as PDE4 inhibitors and are useful for treating PDE4 mediated diseases. 

Pyrimidine compounds and their uses

Novel heterocyclic compounds of the general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts, pharmaceutical compositions, metabolites and prodrugs thereof are described. These compounds are useful in the treatment of immunological diseases, inflammation, pain disorder, rheumatoid arthritis; osteoporosis; multiple myeloma; uveititis; acute and chronic myelogenous leukemia; atherosclerosis; cancer; cachexia; ischemic-induced cell-damage; pancreatic beta cell destruction; osteoarthritis; rheumatoid spondylitis; gouty arthritis; inflammatory bowel disease; adult respiratory distress syndrome (ARDS); psoriasis; Crohn's disease; allergic rhinitis; ulcerative colitis; anaphylaxis; contact dermatitis; muscle degeneration; asthma; COPD; bone resorption diseases; multiple sclerosis; sepsis; septic shock; toxic shock syndrome and fever. More particularly these compounds are useful as PDE4 inhibitors, and useful for treating PDE4 mediated diseases. 

Heterocycles

Growing community of inventors

Chennai, India

Maruthikumar Narayanam